TAMPA, Fla. — As Neutra Corp. (OTCQB: NTRR) and other wellness companies prepare for the expected nationwide legalization of cannabis in Canada, an economist at a major investment bank estimates that the country’s cannabis market could surpass USD $7 billion annually.
Marijuana Business Daily reports that Avery Shenfeld, an economist with CIBC World Markets, based the impressive figure on sales numbers on consumption estimates for Colorado and Canada. Canadian legalization has been seen as a foregone conclusion by many industry observers since October, when the nation elected Justin Trudeau as its prime minister. Trudeau made repeated campaign promises to legalize and regulate cannabis for adult use.
Soon, Canada could become the second country in the world after Uruguay to fully legalize the plant, kicking off an enormous boom in investment and business opportunities. NTRR plans to be ready when it happens. $7 billion worth of demand will require a great deal of cannabis crops, and NTRR is working to help ensure consumers have access to top-quality plants grown without the use of harsh chemicals unfit for consumption. Alongside its joint venture partner, Surface to Air Solutions (S2O2), NTRR is working to offer cannabis growers and other businesses a suite of horticultural technologies designed to reduce or eliminate the industry’s reliance upon pesticides to produce healthy crops.
To further capitalize on the projected growth of the Canadian cannabis industry, the company formed another joint venture last month with Vancouver-based Oceanview Health Services Ltd. to help research cutting-edge topical creams, oils, salves, lotions and other products that have been infused with medicinal cannabis. Oceanview is currently preparing to debut a new brand of cannabis-infused topical products, BeKind Topicals, in markets where cannabis is legal and regulated.